These MIP-GFP mice express a transgene containing a fusion gene joining enhanced green fluorescent protein to a fragment of the human growth hormone 1. Homozygotes develop diabetes by 9 weeks of age.
Manami Hara, University of Chicago
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Reporter) |
The expression of fluorochromes in the beta cells of hemizygous Ins1-EGFP transgenic mice elicit pathophysiological changes which may complicate interpretations if islets from this model are used in transplantation studies. These pathophysiological changes alter the normal pathogenic progression in the NOD mouse model of autoimmune diabetes. Preliminary studies indicate that hemizygous mice are not suitable as recipients of diabetogenic T cells.
Donating investigator reports transgenic mice develop normally and behave similarly to controls with respect to glucose tolerence and and pancreatic insulin content. Histology confirms transgenic mice have normal islet architecture with coexpression of insulin and GFP. The enhanced GFP reporter allows the beta cells to be easily identified and purified for further studies.
Studies completed at The Jackson Laboratory indicate there is strong non-mosaic expression of green fluorescent protein in NOD/LtJ-Tg(Ins1-EGFP/GH1)14Hara/HaraJ islets. 100% of homozygous Ins1-EGFP transgenic males and females, identified by qPCR, become diabetic by 9 weeks of age. Pancreatic histopathology of homozygous mice shows beta cell loss without insulitis.
Hemizygous Ins1-EGFP mice are viable and are used for breeding. A 30-week incidence study comparing NOD/LtJ controls with mice hemizygous for the Ins1-EGFP transgene shows severely depressed diabetes incidence in these hemizygotes, with males atypically at greater risk than females. Glucose tolerance in prediabetic, Ins1-EGFP transgenic hemizygous 8-week-old males is selectively impaired compared to wild type controls. Although these 8-week-old Ins1-EGFP transgenic and wild type males did not differ in plasma insulin content; a significant decline was noted in hemizygous Ins1-EGFP transgenic males compared to normoglycemic wildtype males when sampled at 30 wk. Adoptive transfer of highly diabetogenic CTL (AI4 TCRTg Rag) CD8+ T cells produced diabetes within 8 days post-injection into NOD/Lt females, but failed to produce any diabetes or even home to islets weeks after injection into hemizygous females. Pancreatic histopathology of 31 week old, non-diabetic, hemizygous Ins1-EGFP transgenic males and females indicate peri and intra islet fibrosis, peri-insulitis and depleted beta cell granulation in 70% of the animals, while only 30% of the mice have intra islet insulitis.
This model provides a valuable tool for studying beta-cell biology, including identification of progenitor cells.
This transgenic allele expresses Enhanced Green Fluorescent Protein fused to a 2.1kb fragment of human Growth Hormone under the control of Mouse Insulin Promoter 1. The transgenic construct was injected directly into NOD/LtJ oocytes. Founder 14 was mated to NOD/LtJ. In 2005, The Jackson Laboratory recieved transgenic progeny from the founder, backcrossed once to NOD/LtJ prior to brother-sister mating.
Expressed Gene | GH1, growth hormone 1, human |
---|---|
Expressed Gene | GFP, Green Fluorescent Protein, |
Site of Expression | Pancreatic islets |
Allele Name | transgene insertion 14, Manami Hara |
---|---|
Allele Type | Transgenic (Reporter) |
Allele Synonym(s) | MIP-GFP; NOD-MIP-GFP |
Gene Symbol and Name | Tg(Ins1-EGFP/GH1)14Hara, transgene insertion 14, Manami Hara |
Gene Synonym(s) | |
Promoter | Ins1, insulin 1, rat |
Expressed Gene | GH1, growth hormone 1, human |
Expressed Gene | GFP, Green Fluorescent Protein, |
Site of Expression | Pancreatic islets |
Strain of Origin | NOD/ShiLtJ |
Chromosome | UN |
General Note | Transgenic mice develop normally and exhibit glucose tolerance and pancreatic insulin levels similar to those of controls. Histological analysis reveals normal islet architecture and coexpression of insulin and EGFP (J:100005) |
Molecular Note | The transgene comprises a DNA fragment containing the mouse insulin 1 promoter, extending from 8.5 kb upstream of the transcription initiation site to nucleotide +12, driving expression of a fusion gene joining the 7.6-kb coding region of the enhanced green fluorescent protein (EGFP) gene to a 2.1-kb fragment of the human growth hormone 1 gene that confers high-level expression. |
Mutations Made By | Manami Hara, University of Chicago |
When using the NOD.MIP-GFP mouse strain in a publication, please cite the originating article(s) and include JAX stock #005282 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or Non carrier for Tg(Ins1-EGFP/GH1)14Hara |
Frozen Mouse Embryo | NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara/HaraJ Frozen Embryos | $2595.00 |
Frozen Mouse Embryo | NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara/HaraJ Frozen Embryos | $2595.00 |
Frozen Mouse Embryo | NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara/HaraJ Frozen Embryos | $3373.50 |
Frozen Mouse Embryo | NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara/HaraJ Frozen Embryos | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.